Yahoo
Tokyo - Delayed Quote JPY

JCR Pharmaceuticals Co., Ltd. (4552.T)

544.00 +33.00 (+6.46%)
At close: October 30 at 3:30:00 PM GMT+9
View in AlphaSpace Currency in JPY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
38,931,000
40,319,000
33,072,000
42,871,000
34,343,000
Cost of Revenue
11,563,000
10,134,000
10,902,000
11,620,000
8,886,000
Gross Profit
27,368,000
30,185,000
22,169,000
31,251,000
25,456,000
Operating Expense
32,696,000
29,629,000
28,389,000
23,719,000
20,480,000
Operating Income
-5,328,000
556,000
-6,220,000
7,532,000
4,976,000
Net Non Operating Interest Income Expense
-505,000
-317,000
-42,000
25,000
-11,000
Pretax Income
-3,125,000
3,224,000
-5,983,000
7,244,000
5,412,000
Tax Provision
252,000
1,017,000
-1,586,000
1,707,000
1,625,000
Net Income Common Stockholders
-3,399,000
2,178,000
-4,460,000
5,507,000
3,772,000
Diluted NI Available to Com Stockholders
-3,399,000
2,178,000
-4,460,000
5,507,000
3,772,000
Basic EPS
-27.83
17.87
-36.02
44.13
30.35
Diluted EPS
-27.84
17.87
-36.02
43.92
30.22
Basic Average Shares
122,049.42
121,880.25
123,820.10
124,790.39
124,307.71
Diluted Average Shares
122,049.42
121,880.25
123,820.10
125,387.07
124,818
Total Operating Income as Reported
-5,328,000
555,000
-6,219,000
7,531,000
4,975,000
Total Expenses
44,259,000
39,763,000
39,291,000
35,339,000
29,366,000
Net Income from Continuing & Discontinued Operation
-3,399,000
2,178,000
-4,460,000
5,507,000
3,772,000
Normalized Income
-4,821,600
541,232.94
-5,100,846.40
5,522,280
3,776,200
Interest Income
73,000
81,000
113,000
111,000
33,000
Interest Expense
578,000
398,000
155,000
86,000
44,000
Net Interest Income
-505,000
-317,000
-42,000
25,000
-11,000
EBIT
-2,547,000
3,622,000
-5,828,000
7,330,000
5,456,000
EBITDA
-368,000
6,179,000
-2,454,000
10,527,000
7,453,000
Reconciled Cost of Revenue
11,563,000
10,134,000
10,902,000
11,620,000
8,886,000
Reconciled Depreciation
2,179,000
2,557,000
3,374,000
3,197,000
1,997,000
Net Income from Continuing Operation Net Minority Interest
-3,399,000
2,178,000
-4,460,000
5,507,000
3,772,000
Total Unusual Items Excluding Goodwill
2,371,000
2,391,000
872,000
-20,000
-6,000
Total Unusual Items
2,371,000
2,391,000
872,000
-20,000
-6,000
Normalized EBITDA
-2,739,000
3,788,000
-3,326,000
10,547,000
7,459,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
948,400
754,232.94
231,153.60
-4,720
-1,800
3/31/2023 - 11/17/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: